Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1997
11/05/1997EP0662818B1 Cosmetic composition containing retinol
11/05/1997EP0636119B1 Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase
11/05/1997EP0544756B1 1,2,5,6-tetrahydro-1-methylpyridines, their preparation and use
11/05/1997CN1164234A Pyrrolo £2,3-d| pyrimidines and their use
11/05/1997CN1164194A Remedy for diseases caused by IL-6 production
11/05/1997CN1164192A Multicatalytic protease inhibitors
11/05/1997CN1163934A Protein with thrombocytopoietic factor active
11/05/1997CN1163933A Protein with thrombocytopoietic factor active
11/05/1997CN1163895A Novel prodrugs for therapy of tumors and inflammatory disorders
11/05/1997CN1163773A Health granule
11/04/1997US5684151 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines
11/04/1997US5684046 Hydrogenated naphthalenes and related LTB4 antagonists
11/04/1997US5684041 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/04/1997US5684034 1H-indole-3-acetamide sPLA2 inhibitors
11/04/1997US5684033 Antiarthritic agents, analgesics and migraine
11/04/1997US5684030 2-substituted benzimidazole derivatives
11/04/1997US5684028 Sulphorous derivatives of imidazole, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions
11/04/1997US5684020 Piperazine, piperidine and 1,2,5,6-tetrahydropyridine
11/04/1997US5684017 Antiarthritic agents, rheumatic diseases, antidiabetic agents for inhibiting interloeukins
11/04/1997US5684015 Angiotensin antagonist as hypotensive agents and cardiovascular disorders
11/04/1997US5684008 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
11/04/1997US5683997 Substituted benzazepinones
11/04/1997US5683151 Hydraulic unit for traction-controlled motor vehicle brake systems
11/04/1997CA2083698C (+)-alpha-(2,3-dimethoxyphenyl)-1- [2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
10/1997
10/30/1997WO1997040158A1 Epimorphin antagonist and process for producing the same
10/30/1997WO1997040134A2 Human dnase ii
10/30/1997WO1997040069A2 Secreted proteins and polynucleotides encoding them
10/30/1997WO1997040066A1 Suppression of immune response via inhibition of cathepsin s
10/30/1997WO1997040045A1 Heterocyclic compounds and their preparation and use
10/30/1997WO1997040044A1 Heterocyclic compounds
10/30/1997WO1997040043A1 Heterocyclic compounds
10/30/1997WO1997040042A1 Heterocyclic compounds
10/30/1997WO1997040038A1 Piperidines and pyrrolidines
10/30/1997WO1997040031A1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors
10/30/1997WO1997040028A1 Urea derivatives as inhibitors of impdh enzyme
10/30/1997WO1997040019A1 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick
10/30/1997WO1997040017A2 Modulators of molecules with phosphotyrosine recognition units
10/30/1997WO1997040016A1 Heterocyclic compounds
10/30/1997WO1997040015A1 Tricyclic aminoalkylcarboxamides; novel dopamine d3 receptor subtype specific ligands
10/30/1997WO1997040012A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
10/30/1997WO1997039767A1 Methods for inducing bone formation
10/30/1997WO1997039766A1 Regulation of cellular volume via chloride conductive polypeptide channels
10/30/1997WO1997039765A1 Component b as cicatrizant
10/30/1997WO1997039753A1 Heterocyclic compounds
10/30/1997WO1997039749A2 Method for the prevention and treatment of cachexia and anorexia
10/30/1997WO1997039748A1 Modulators of molecules with phosphotyrosine recognition units
10/30/1997WO1997039734A1 Methods of regulating skin condition with centella asiatica extract
10/30/1997WO1997039733A1 Methods of regulating skin appearance with vitamin b3 compound
10/30/1997WO1997034567A3 Method for treating huntington's disease using glial cell line-derived neurotrophic factor (gdnf) protein product
10/30/1997WO1997006255A3 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
10/30/1997CA2252573A1 Heterocyclic compounds
10/30/1997CA2252563A1 Heterocyclic compounds and their preparation and use
10/30/1997CA2252527A1 Heterocyclic compounds
10/30/1997CA2252385A1 Piperidines and pyrrolidines
10/30/1997CA2252088A1 Secreted proteins and polynucleotides encoding them
10/30/1997CA2251989A1 Tricyclic aminoalkylcarboxamides; novel dopamine d3 receptor subtype specific ligands
10/30/1997CA2251974A1 Heterocyclic compounds
10/30/1997CA2251808A1 Methods for inducing bone formation
10/30/1997CA2251727A1 Regulation of cellular volume via chloride conductive polypeptide channels
10/30/1997CA2251714A1 Suppression of immune response via inhibition of cathepsin s
10/30/1997CA2251356A1 Component b as cicatrizant
10/30/1997CA2250873A1 Heterocyclic compounds
10/30/1997CA2250472A1 Heterocyclic compounds
10/29/1997EP0803505A1 Inhibitors of metalloproteases, process for their preparation and pharmaceutical compositions containing them
10/29/1997EP0803503A1 Acids and esters of diosmetin and pharmaceutical compositions containing them
10/29/1997EP0803256A1 Drug for relieving side effects caused by immunosuppressants
10/29/1997EP0803252A2 Treatment of central nervous system disorders with imidazole angiotensin-II receptor antagonists
10/29/1997EP0803249A2 Cholesterol lowering drink mix compositions
10/29/1997EP0802985A1 Cell cycle regulated repressor and dna element
10/29/1997EP0802917A1 Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
10/29/1997EP0802914A1 Aryl and heteroaryl purine compounds
10/29/1997EP0802912A1 Piperidine derivatives having tachykinin antagonist activity
10/29/1997EP0802909A2 Substituted oxazolidine calpain and/or cathepsin b inhibitors
10/29/1997EP0802908A1 Novel compounds
10/29/1997EP0802902A1 Indole derivatives useful in the treatment of osteoporosis
10/29/1997EP0802897A1 Novel compounds
10/29/1997EP0802801A2 Methods and compositions for treatment of solid tumors in vivo
10/29/1997EP0802797A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
10/29/1997EP0802796A1 Chicken anaemia agent broiler vaccine
10/29/1997EP0802792A1 Therapeutic treatment for inhibiting vascular restenosis
10/29/1997EP0802791A1 3,3-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
10/29/1997EP0637976B1 Medicament for disinfection of the oral cavity
10/29/1997EP0471756B1 Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
10/29/1997CN1163656A Axial flow valve system for linear compressor
10/29/1997CN1163613A 7-azabicyclo£2,2,1|-heptane and heptene derivatives as cholinergic receptor ligands
10/29/1997CN1163604A Substituted r-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors
10/29/1997CN1163566A Quinazolinone pharmaceuticals and use thereof
10/29/1997CN1036263C Preparation of substituted azole
10/28/1997US5681965 Alpha-phenyl tert-butyl nitrone and derivatives as free radical scavengers treating aging, oxidative tissue damage
10/28/1997US5681961 Arylsulphonamides, pharmaceutical compositions containing these compounds and processes for preparing them
10/28/1997US5681956 Useful in diagnosis and treatment of schizophrenia and depression as well as parkinsonism
10/28/1997US5681941 Substituted purines and oligonucleotide cross-linking
10/28/1997US5681933 Immunizing animal with interleukin
10/28/1997US5681863 Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors
10/28/1997US5681858 Cycloalkyl hydroxyureas
10/28/1997US5681841 Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
10/28/1997US5681838 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation
10/28/1997US5681747 Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof
10/28/1997US5681582 Extended release, film-coated tablet of astemizole and pseudoephedrine
10/28/1997US5681568 Device for delivery of substances and methods of use thereof
1 ... 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 ... 1564